InsiderSignal.AI

InsiderSignal.ai

CELC - Celcuity Inc.

Insider Purchase by Baker Bros. Advisors LP (10%)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

5 months ago, Baker Bros. Advisors LP, serving as 10% owner at Celcuity Inc. (CELC), purchased 170,100 shares at $56.27 per share, for a total transaction value of $9,571,319.00. Following this transaction, Baker Bros. Advisors LP now holds 7,211,484 shares of CELC.

This purchase represents a 2.00% increase in Baker Bros. Advisors LP's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, September 8, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, September 10, 2025, 2 days after the trade was made.

Celcuity Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Baker Bros. Advisors LP

Baker Bros. Advisors LP

10%

Baker Bros. Advisors LP is a New York-based hedge fund management firm and registered investment advisor specializing in biotechnology, life sciences, and healthcare investments.[[1]](https://www.revealintelligence.com/r-361d5490f4/)[[2]](https://fintool.com/app/research/funds/hedge-funds/baker-bros-advisors-lp)[[3]](https://www.gurufocus.com/guru/baker+bros.+advisors+lp/summary) Founded in 2000 by brothers Julian Baker and Felix Baker, the firm manages over $18 billion in assets under management as of March 2025, primarily through two pooled investment vehicles: 667, L.P. and Baker Brothers Life Sciences, L.P., serving institutional clients such as Yale and Princeton endowments, pension funds, and high-net-worth families.[[1]](https://www.revealintelligence.com/r-361d5490f4/)[[3]](https://www.gurufocus.com/guru/baker+bros.+advisors+lp/summary) Headquartered at 860 Washington Street in New York, NY, it employs 52-56 people and maintains a secretive profile with no public website.[[1]](https://www.revealintelligence.com/r-361d5490f4/) The firm employs a fundamentally driven, long-term investment strategy, concentrating capital in high-conviction public and private healthcare securities, often taking activist roles.[[2]](https://fintool.com/app/research/funds/hedge-funds/baker-bros-advisors-lp)[[3]](https://www.gurufocus.com/guru/baker+bros.+advisors+lp/summary) Baker Bros. Advisors has a proven track record, including a 25% stake in Seagen that yielded an $8 billion windfall upon its 2023 acquisition by Pfizer, and growth from $250 million AUM in 2003 to over $18 billion today.[[1]](https://www.revealintelligence.com/r-361d5490f4/) As a corporate insider, it recently traded as Director, 10% at Kodiak Sciences Inc. (KOD), reflecting its active involvement in portfolio companies.[user query] Julian Baker holds a business degree from Harvard, while Felix Baker has a PhD in Immunology from Stanford; both serve as co-managing members.[[1]](https://www.revealintelligence.com/r-361d5490f4/)[[3]](https://www.gurufocus.com/guru/baker+bros.+advisors+lp/summary)

View full insider profile →

Trade Price

$56.27

Quantity

170,100

Total Value

$9,571,319.00

Shares Owned

7,211,484

Trade Date

Monday, September 8, 2025

167 days ago

SEC Filing Date

Wednesday, September 10, 2025

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Celcuity Inc.

Company Overview

No company information available
View news mentioning CELC

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/276720

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime